Protein prenylation: From discovery to prospects for cancer treatment

Current Opinion in Chemical Biology

Volumn 2, Issue 1, 1998, Pages 40-48

  Gelb, Michael H ^a   Scholten, Jeffrey D ^b   Sebolt Leopold, Judith S ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EUKARYOTA;

ANTINEOPLASTIC AGENT; P21(RAS) FARNESYL PROTEIN TRANSFERASE; P21(RAS) FARNESYL-PROTEIN TRANSFERASE; TRANSFERASE;

CHEMISTRY; HUMAN; METABOLISM; PROTEIN PROCESSING; REVIEW;

ALKYL AND ARYL TRANSFERASES; ANTINEOPLASTIC AGENTS; HUMANS; PROTEIN ISOPRENYLATION;

EID: 0031993476     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(98)80034-3     Document Type: Article

References (94)

1. Kamiya Y, Sakurai A, Tamura S, Takahashi N: Structure of rhodotorucine A, a novel lipopeptide, inducing mating tube formation in Rhodosporidium toruloides. Biochem Biophys Res Commun 1978, 83:1077-1083.
2. Sakagami Y, Isogai A, Suzuki A, Tamura S, Kitada C, Fujino M: Structure of tremerogen A-10, a peptidal hormone inducing conjugation tube formation in Tremella mesenterica. Agric Biol Chem 1979, 43:2643-2645.
3. Anderegg RJ, Betz R, Carr SA, Crabb JW, Duntze W: Structure of Saccharomyces cerevisiae mating hormone a-factor. Identification of S-farnesyl cysteine as a structural component. J Biol Chem 1988, 263:18236-18240.
4. Habenicht AJR, Glomset JA, Ross R: Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J Biol Chem 1980, 255:5134-5140.
5. Quesney-Huneeus V, Wiley MH, Siperstein MD: Essential role for mevalonate synthesis in DNA replication. Proc Natl Acad Sci USA 1979, 76:5056-5060.
6. Schmidt RA, Schneider CJ, Glomset JA: Evidence for post-translational incorporation of a product of mevanolic acid into Swiss 3T3 cell proteins. J Biol Chem 1984, 259:10175-10180.
7. Sinensky M, Logel J: Defective macromolecule biosynthesis and cell-cycle progression in a mammalian cell starved for mevalonate. Proc Natl Acad Sci USA 1985, 82:3257-3261.
8. Maltese WA, Sheridan KM: Isoprenylated proteins in cultured cells: subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivation. J Cell Physiol 1987, 133:471-481.
9. Sepp-Lorenzino L, Azrolan N, Coleman PS: Cellular distribution of cholesterogenesis-linked, phosphoisoprenylated proteins in proliferating cells. FEBS Lett 1989, 245:110-116.
10. Wolda SL, Glomset JA: Evidence for modification of lamin B by a product of mevalonic acid. J Biol Chem 1988, 263:5997-6000.
11. Beck LA, Hosick TJ, Sinensky M: Incorporation of a product of mevalonic acid metabolism into proteins of Chinese hamster ovaries cell nuclei. J Cell Biol 1988, 107:1307-1316.
12. Farnsworth CC, Wolda SL, Gelb MH, Glomset JA: Human Lamin B Contains a farnesylated cysteine residue. J Biol Chem 1989, 264:20422-20429.
13. Farnsworth CC, Gelb MH, Glomset JA: Identification of geranylgeranyl-modified proteins in HeLa cells. Science 1990, 247:320-322.
14. Rilling HC, Bruenger F, Epstein WW, Crain PF: Prenylated proteins: the structure of the isoprenoid group. Science 1990, 247:318-320.
15. Gelb MH, Farnsworth CC, Glomset JA: Structural Characterization of Prenylated Proteins. In Lipidation of Proteins: A Practical Approach. Edited by Turner AJ. Oxford: IRL Press; 1991.
16. Casey PJ, Solski PA, Der CJ, Buss JE: p21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci USA 1989, 86:8323-8327.
17. Schafer WR, Trueblood CE, Yang C-C, Mayer MP, Rosenberg S, Poulter CD, Kim S-H, Rine J: Enzymatic coupling of cholesterol intermediates to a mating phermone precursor and to the Ras protein. Science 1990, 249:1133-1139.
18. Hancock JF, Magee Al, Childs JE, Marshall CJ: All Ras proteins are polyisoprenylated but only some are palmitoylated. Cell 1989, 57:1167-1177.
19. Yamane HK, Farnsworth CC, Xie H, Howald W, Fung BK-K, Clarke S, Gelb MH, Glomset JA: Brain G protein subunits contain an all-trans-geranylgeranyl cysteine methyl ester at their carboxyl termini. Proc Natl Acad Sci USA 1990, 87:5868-5872.
20. Mumby SM, Casey PJ, Gilman AG, Gutowski S, Sternweis PC: G protein γ subunits contain a 20-carbon isoprenoid. Proc Natl Acad Sci USA 1990, 87:5873-5877.
21. Farnsworth CC, Kawata M, Yoshida U, Takai Y, Gelb MH, Glomset JA: C terminus of the small GTP-binding protein smg p25A contains two geranylgeranylated cysteine residues and a methyl ester. Proc Natl Acad Sci USA 1991, 88:6196-6200.
22. Zhang FL, Casey PJ: Protein prenylation: molecular mechanisms and functional consequences. Ann Rev Biochem 1996, 65:241-269.
23. Yokoyama K, Lin Y, Stuart KD, Gelb MH: Prenylation of proteins Trypanosoma brucei. Mol Biochem Parasitol 1997, 87:61-69.
24. Ma Y-T, Rando RR: A microsomal endoprotease that specifically cleaves isoprenylated peptides. Proc Natl Acad Sci USA 1992, 89:6275-6279.
25. Jang GF, Yokoyama K, Gelb MH: A prenylated protein-specific endoprotease in rat liver microsomes that produces a carboxyl-terminal tripeptide. Biochemistry 1993, 32:9500-9507.
26. Boyartchuck VL, Ashby MN, Rine J: Modulation of Ras and a-factor function by carboxyl-terminal proteolysis. Science 1997, 275:1796-1800. This paper identifies two genes in yeast required for proteolysis of prenylated proteins. Genetic studies also point to the importance of proteolysis for Ras function in yeast.
27. Tan EW, Perez-Sala, Canada FJ, Rando RR: Identifying the recognition unit for G protein methylation. J Biol Chem 1991, 266:10719-10722.
28. Stephenson RC, Clarke S: Identification of a C-terminal protein carboxyl methyltransferase in rat liver membranes utilizing a synthetic farnesyl cysteine containg peptide substrate. J Biol Chem 1990, 265:16248-16254.
29. Stephenson RC, Clarke S: Characterization of a rat liver protein carboxyl methyltransferase involved in the maturation of proteins with the -CXXX C-terminal sequence motif. J Biol Chem 1992, 267:13314-13319.
30. Pillinger MH, Volker C, Stock JB, Weissmann G, Philips MR: Characterization of a plasma membrane-associated prenylcysteine-directed alpha carboxyl methyltransferase in human neutrophils. J Biol Chem 1994, 269:1486-1492.
31. Heilmeyer LM Jr, Serwe M, Weber C, Metzger J, Hoffmann-Posorske E, Meyer HE: Farnesyl cysteine is a constituent of the αand βsubunits of rabbit skeletal muscle phosphorylase kinase. Proc Natl Acad USA 1993, 89:9554-9558.
32. Gelb MH, Reiss Y, Ghomashchi F, Farnsworth CC: Exploring the specificity of prenyl protein-specific methyltranferase with synthetic prenylated Rab peptides. Bioorg Med Chem Lett 1995, 8:881-886.
33. Smeland T, Seabra MC, Goldstein JL, Brown MS: Geranylgeranylated Rab proteins terminating in Cys-Ala-Cys, but not Cys-Cys, are carboxyl-methylated by bovine brain membranes in vitro. Proc Natl Acad Sci USA 1994, 91:10712-10716.
34. Giner JL, Rando RR: Novel methyltransferase activity modifying the carboxy terminal bis(geranylgeranyl)-Cys-Ala-Cys structure of small GTP-binding proteins. Biochemistry 1994, 33:15116-15123.
35. Jackson C-S, Zlatkine-P B-C, Kabouridis P, Mehul B, Parenti M, Milligan G, Ley SC, Magee Al: Dynamic protein acylation and the regulation of localization and function of signal-transducing proteins. Biochem Soc Trans 1995, 23:568-571.
36. Nigg EA, Kitten GT, Vorburger K: Targeting lamin proteins to the nuclear envelope: the role of CaaX box modifications. Biochem Soc Trans 1992, 20:500-504.
37. Hancock JF, Cadwallader K, Marshall CJ: A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of Ras proteins. EMBO J 1991, 10:641-646.
38. Dudler T, Gelb MH: Palmitoylation of Ha-Ras facilitates membrane binding, activation of downstream effectors, and meiotic maturation in Xenopus oocytes. J Biol Chem 1996, 271:11541-11547. This paper shows for the first time that palmitoylation of Ras potentiates its function.
39. Ghomashchi F, Zhang X, Gelb MH: Binding of prenylated and poly-basic peptides to membranes: affinities and interversicle exchange. Biochemistry 1995, 34:11910-11918.
40. Dudler T, Gelb MH: Replacement of the H-Ras farnesyl group by lipid analogues: implications for downstream processing and effector activation in Xenopus oocytes. Biochemistry 1997, 36:12434-12441. This is the first in vivo study of the role of the structure of the farnesyl group in supporting the function of a prenylated protein.
41. McGeady P, Kuroda S, Shimizu K, Takai Y, Gelb MH: The farnesyl group of H-Ras facilitates the activation of a soluble upstream activator of mitogen-activated protein kinase. J Biol Chem 1995, 270:26347-26351.
42. McGeady P, Porfiri E, Gelb MH: The farnesyl group activates Ras toward guanine nucleotide exchange catalyzed by the sos protein. Bioorg Med Chem Lett 1997, 7:145-150.
43. Willumsen BM, Cox AD, Solski PA, Der CJ, Buss JE: Novel determinants of H-Ras plasma membrane localization and transformation. Oncogene 1996, 13:1901-1909. This is the first report showing that palmitoylated H-Ras is poorly functional in a mammalian cell.
44. Inglese J, Koch WJ, Caron MG, Lefkowitz RJ: Isoprenylation in regulation of signal transduction by G-protein-coupled receptor kinases. Nature 1992, 359:147-150.
45. Fukada Y, Takao T, Ohguro H, Yoshizawa T, Akino T, Shimonishi Y: Farnesylated γ-subunit of photoreceptor G protein indispensable for GTP-binding. Nature 1990, 346:658-660.
46. Ohguro H, Fukada Y, Yoshizawa T, Saito T, Akino T: A specific β-subunit of transducin stimulates ADP-ribosylation of the α-subunit by pertussis toxin. Biochem Biophys Res Comm 1990, 167:1235-1241.
47. Iniguez-Lluhi JA, Simon Ml, Robishaw JD, Gilman AG: G Protein β subunits synthesized in Sf9 cells. J Biol Chem 1992, 267:23409-23417.
48. Wildman DE, Tamir H, Leberer E, Northup JK, Dennis M: Prenyl modification of guanine nucleotide regulatory protein 2 subunits is not required for interaction with the transducin ot subunit or rhodopsin. Proc Natl Acad Sci USA 1993, 90:794-798.
49. Ohguro H, Fukada Y, Takao T, Shimonishi Y, Yoshizawa T, Akino T: Carboxyl methylation and farnesylation of transducin-subunit synergistically enhances its coupling with metarhodopsin II. EMBO J 1991, 10:3669-3674.
50. Fukada Y, Ohguro H, Saito T, Yoshizawa T, Akino T: βγ Subunit of bovine transducin composed of two components with distinctive α-subunits. J Biol Chem 1989, 264:5937-5943.
51. Fukada Y, Matsuda T, Kokame K, Takao T, Shimonishi Y, Akino T, Yoshizawa T: Effects of carboxy methylation of photoreceptor G protein α-subunit in visual transduction. J Biol Chem 1994, 269:5163-5170.
52. Bigay J, Faurobert E, Franco M, Chabre M: Roles of lipid modifications of transducin subunits in their GDP-dependent association and membrane binding. Biochemistry 1994, 33:14081-14090.
53. Musha T, Kawata M, Takai Y: The geranylgeranyl moiety but not the methyl moiety of the smg-25A/ra63a protein is essential for the interactions with membrane and its inhibitory GDP/GTP exchange protein. J Biol Chem 1992, 267:9821-9825.
54. ras farnesyl: protein transferase by Cys-AAX tetrapeptides. Cell 1990, 62:81-88.
55. Moomaw JF, Casey PJ: Mammalian protein geranylgeranyltransferase. Subunit composition and metal requirements. J Biol Chem 1992, 267:17438-17443.
56. Yokoyama K, Gelb MH: Purification of a mammalian protein geranylgeranyltransferase. Formation and catalytic properties of an enzyme-geranylgeranyl pyrophosphate complex. J Biol Chem 1993, 268:4055-4060.
57. Seabra MC, Brown MS, Slaughter CA, Sudhof TC, Goldstein JL: Purification of component A of Rab geranylgeranyl transferase: possible identity with the choroideremia gene product. Cell 1992, 70:1049-1057.
58. Seabra MC, Goldstein JL, Sudhof TC, Brown MS: Rab geranylgeranyl transferase. A multisubunit enzyme that prenylates GTP-binding proteins terminating in Cys-X-Cys or Cys-Cys. J Biol Chem 1992, 267:14497-1503.
59. Casey PJ, Seabra MC: Protein prenyltransferases. J Biol Chem 1996, 271:5289-5292.
60. Yokoyama K, Goodwin GW, Ghomashchi F, Glomset JA, Gelb MH: A protein geranylgeranyltransferase from bovine brain: implications for protein prenylation specificity. Proc Natl Acad Sci USA 1991, 88:5302-5306.
61. Moores SL, Schaber MD, Mosser SD, Rands E, O'Hara MB, Garsky VM, Marshall MS, Pompliano DL, Gibbs JB: Sequence dependence of protein isoprenylation. J Biol Chem 1991, 266:14603-14610.
62. Kinsella BT, Erdman RA, Maltese WA: Posttranslational modification of Ha-ras p21 by farnesyl versus geranylgeranyl isoprenoids is determined by the COOH-terminal amino acid. Proc Natl Acad Sci USA 1991, 88:8934-8938.
63. Farnsworth CC, Seabra MC, Ericsson LH, Gelb MH, Glomset JA: Rab Geranylgeranyl Transferase Catalyzes the Geranylgeranylation of Adjacent Cysteines in the Small GTPases, Rab1A, Rab3A, and Rab5A. Proc Natl Acad Sci USA 1994, 91:11963-11967.
64. Pompliano DL, Rands E, Schaber MD, Mosser SD, Anthony NJ, Gibbs JB: Steady-state kinetic mechanism of Ras farnesyl:protein transferase. Biochemistry 1992, 31:3800-3807.
65. Yokoyama K, McGeady P, Gelb MH: Mammalian protein geranylgeranyltransferae-I: substrate specificity, kinetic mechanism, metal requirements, and affinity labeling. Biochemistry 1995, 34:1344-1354.
66. Furfine ES, Leban JJ, Landavazo A, Moomaw JF, Casey PJ: Protein farnesyltransferase: kinetics of farnesyl pyrophosphate binding and product release. Biochemistry 1995, 34:6857-6862.
67. Yokoyama K, Zimmerman KZ, Scholten JD, Gelb MH: Differential prenyl pyrophosphate binding to mammalian protein geranylgeranyltransferase-I and protein farnesyltransferase and its consequence on the specificity of protein prenylation. J Biol Chem 1997, 272:3944-3952. This paper puts the substrate specificity of PFT and PGGT-I into a quantitatively correct form and provides clarification of a controversial issue.
68. Tschantz WR, Furfine ES, Casey PJ: Substrate bonding is required for release of product from mammalian protein farnesyl transferase. J Biol Chem 1997, 272:9989-9993. This study describes a rare enzymological process.
69. Huang C-C, Casey PJ, Fierke CA: Evidence for a catalytic role of zinc protein farnesyltransferase. J Biol Chem 1997, 272:20-23.
70. Mu Y, Omer CA, Gibbs RA: On the stereochemical course of human protein-farnesyl transferase. J Am Chem Soc 1996, 118:1817-1823.
71. Pompliano DL, Schaber MD, Mosser SD, Omer CA, Shafer JA, Gibbs JB: Isoprenoid diphosphate utilization by recombinant human farnesyl: protein transferase: interactive binding between substrates and a preferred kinetic pathway. Biochemistry 1993, 32:8341-8347.
72. James GL, Goldstein JL, Brown MS: Polylysine and CVIM sequences of K-RasB dictate specificity and confer resistance to benzodiazepine peptidomimetic inhibitors. J Biol Chem 1995, 270:6221-6226.
73. Rowell CA, Kowalczyk JJ, Lewis MD, Garcia AM: Direct demonstration of geranylgeranylation and farnesylation of Ki-Ras in vivo. J Biol Chem 1997, 272:14093-14097. This paper connects the in vitro observations of PFT and PGGT-I specificity [67••] to the in vivo situation.
74. Park H-W, Boduluri SR, Moomaw JF, Casey PJ, Beese LS: Crystal structure of protein farnesyltransferase at 2.25 Angstrom resolution. Science 1997, 275:1800-1804. This is the first and only X-ray structure of a protein prenyltransferase.
75. Bukhitiyarov YE, Omer CA, Allen CM: Photoreactive analogues of prenyl diphosphates as inhibitors and probes of human farnesyltransferase and geranylgeranyltransferase type I. J Biol Chem 1995, 270:19035-19040.
76. Fu H-W, Moomaw JF, Moomaw CR, Casey PJ: Identification of a cysteine residue essential for activity of protein farnesyltransferase. J Biol Chem 1996, 271:28541-28548.
77. Dolence JM, Rozema DB, Poulter CD: Yeast protein farnesyltransferase. Site directed mutagenesis of conserved residues in the B-subunit. Biochemistry 1997, 36:9246-9252.
78. Leonard DM: Ras farnesyltransferase: A new therapeutic target. J Med Chem 1997, 40:2971-2990.
79. Qian Y, Sebti SM, Hamilton AD: Farnesyltransferase as a target for anticancer drug design. Biopolymers 1997, 43:25-41.
80. Scholten JD, Zimmerman KK, Oxender GM, Leonard D, Sebolt-Leopold J, Gowan J, Hupe DJ: Synergy between anions and farnsyldiphosphate competitive inhibitors of farnesyl: protein transferase. J Biol Chem 1997, 272:18077-18081.
81. Njorge FG, Doll RJ, Vibulbhan B, Avare CS, Bishop R, Petrin J, Kirsschmeier P, Carruthers Nl, Wong JW, Albanese MM et al.: Discovery of novel nonpeptide tricyclic inhibitors of Ras farnesyl protein transferase. Bioorganic Med Chem 1997, 5:101-113.
82. McNamara DJ, Dobrusin E, Leonard DM, Shuler KR, Kaltenbronn JS, Quin J, Bur S, Thomas CE, Doherty AM, Scholten JD et al.: C-terminal modifications of histidyl-(N-benzylglycinamides) to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in mice. J Med Chem 1997, 40:3319-3322.
83. Kato K, Cox AD, Hisaka MM, Graham SM, Buss JE, Der CJ: Isoprenoid addition to Ras proteins is the critical modification for its membrane association and transforming activity. Proc Natl Acad Sci USA 1992, 89:6403-6407.
84. Nagasu T, Yoshimatsu K, Rowell C, Lewis MD, Garcia AM: Inhibition of human tumor xenograft growth by treatment with the farnesyltransferase inhibitor B956. Cancer Res 1995, 55:5310-5314.
85. Sun J, Qian Y, Hamilton AD, Sebti SM: Ras CAAX peptidomimetic FTI 276 selectively blocks tumour growth in nude mice of a human lung carcinoma with k-ras mutation and p53 deletion. Cancer Res 1995, 55:4243-4247.
86. Kohl NE, Omer CA, Conner MW, Anthony NJ, Davide JP, Desolms SJ, Giuliana EA, Gomez RP, Graham SL, Hamilton K, et al.: Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nature Med 1995, 1:792-797.
87. Liu M, CP, Lee S, Li Z, Bishop WR, Kirschmeier P, Doll RJ, Mallams AK, Rossman RR, Dell J, Lipari P et al.: SCH59228, a novel tricyclic inhibitor of farnesyl protein transferase, potently blocks the growth of Ras transformed fibroblasts and human tumor cell lines in nude mice. Proc Amer Assoc Cancer Res 1997, 38:349. This is a recent example of the use of protein farnesyltransferase inhibitors to alter tumor growth in animals.
88. James GL, Goldstein JL, Brown MS, Rawson TE, Somers TC, McDowell RS, Crowley CW, Lucas BK, Levinson AD, Marsters JCJ: Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. Science 1993, 260:1937-1942.
89. Graham SM, Vojtek AB, Huff SY, Cox AD, Clark GJ, Cooper JA, Der CJ: TC21 causes transformation by Raf-independent signaling pathways. Mol Cell Biol 1996, 16:6132-6140.
90. James GL, Goldstein JL, Brown MS: Resistance of K-RasBV12 proteins to farnesyltransferase inhibitors in Rat1 cells. Proc Natl Acad Sci USA 1996, 93:4454-4458. This paper describes important findings that are relevant to the development of protein farnesyltransferase inhibitors of anticancer agents.
91. Sepp-Lorenzino L, Ma Z, Rands E, Kohl NE, Gibbs JB, Oliff A, Rosen N: A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines. Cancer Res 1995, 55:5302-5309.
92. Cox AD, Der CJ: Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras? BBA Rev Cancer 1997, 1333:F51-71. This review underscores the recent notion that Ras farnesylation may not be the only relevant target for developing PFT inhibitors as anticancer agents.
93. Bernhard EJ, Kao G, Cox AD, Sebti SM, Hamilton AD, Muschel RJ, McKenna WG: The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts. Cancer Res 1996, 56:1727-1730.
94. Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Connor RW, Bridges AJ: A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 1994, 265:1093-1095.